There are no significant Insider Shareholders in Terns Pharmaceuticals as of December 12, 2025.
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| James E Flynn | 2,382,033 | 09 Feb, 2021 | |
| Advisors Llc Orbimed | 755,635 | 17 Jul, 2024 | |
| Carl L Gordon | 755,635 | 17 Jul, 2024 | |
| Biosciences Fund V, L.P. Lav | 529,762 | 28 Nov, 2022 | |
| Hongbo Lu | 476,190 | 17 Sep, 2024 | |
| Capital Viii, Llc Vivo | 357,353 | 09 Feb, 2021 | |
| Opportunity, Llc Vivo | 268,573 | 03 Apr, 2024 | |
| Seokho Bryan Yoon | COO And General Counsel | 91,940 | 04 Jun, 2024 |
| Erin Quirk | President And Head Of R&D | 75,000 | 25 Jan, 2024 |
| Mark J. Vignola | Chief Financial Officer | 74,752 | 06 Jan, 2025 |
| Emil Kuriakose | Chief Medical Officer | 51,520 | 02 Oct, 2025 |
| Amy L. Burroughs | Chief Executive Officer | 47,083 | 25 Jun, 2025 |
| Andrew Gengos | Chief Financial Officer | 25,000 | 30 Jun, 2025 |
| Senthil Vel Sundaram | Chief Executive Officer | 9,770 | 02 Jun, 2023 |
| Melita Sun Jung | Chief Business Officer | 2,250 | 03 Feb, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Nov, 2025 | Jill M. Quigley | Common Stock | A | 24,520 | $9.24 | 24,520 | D | M |
| 04 Nov, 2025 | Jill M. Quigley | Common Stock | D | 24,520 | $18.00 | 0 | D | S |
| 01 Oct, 2025 | Emil Kuriakose | Common Stock | D | 944 | $7.85 | 51,520 | D | S |
| 01 Jul, 2025 | Emil Kuriakose | Common Stock | D | 853 | $4.27 | 52,464 | D | S |
| 27 Jun, 2025 | Andrew Gengos | Common Stock | A | 5,000 | $3.93 | 20,000 | D | P |
| 27 Jun, 2025 | Andrew Gengos | Common Stock | A | 5,000 | $3.93 | 25,000 | D | P |
| 25 Jun, 2025 | Amy L. Burroughs | Common Stock | A | 23,314 | $3.87 | 47,083 | D | P |
| 25 Jun, 2025 | Amy L. Burroughs | - | - | 47,083 | D | |||
| 13 Jun, 2025 | Andrew Gengos | - | - | 5,000 | D | |||
| 13 Jun, 2025 | Andrew Gengos | Common Stock | A | 5,000 | $3.75 | 5,000 | D | P |
| 13 Jun, 2025 | Andrew Gengos | - | - | 10,000 | D | |||
| 13 Jun, 2025 | Andrew Gengos | Common Stock | A | 5,000 | $3.72 | 10,000 | D | P |
| 16 Jun, 2025 | Andrew Gengos | - | - | 15,000 | D | |||
| 16 Jun, 2025 | Andrew Gengos | Common Stock | A | 5,000 | $3.95 | 15,000 | D | P |
| 01 Apr, 2025 | Emil Kuriakose | Common Stock | D | 952 | $2.49 | 53,317 | D | S |
| 30 Nov, 2024 | Amy L. Burroughs | Common Stock | A | 510 | $5.11 | 19,609 | D | P |
| 30 Nov, 2024 | Melita Sun Jung | Common Stock | A | 2,250 | $5.11 | 2,250 | D | P |
| 30 Nov, 2024 | Melita Sun Jung | - | - | 2,250 | D | |||
| 02 Jan, 2025 | Jill M. Quigley | Common Stock | D | 6,240 | $5.72 | 8,760 | D | S |
| 02 Jan, 2025 | Jill M. Quigley | - | - | 8,760 | D |